NT5E and neoplasm: Together, in this modified MC38-CRC model, where tumor Cd73 is inactivated with adequate presences of CAFs, the synergistic effects of adenosinergic antagonism and CD73-blockade was recapitulated as those seen in the EG7 tumor model.